COMMUNIQUÉS West-GlobeNewswire

Progenics Pharmaceuticals Announces Presentations at the 2019 American Urological Association (AUA) Annual Meeting
03/04/2019
Results from Phase 2/3 OSPREY Trial of PyL in Prostate Cancer Selected for an Oral Presentation NEW YORK, April 03, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company developing [...]
Pluristem Therapeutics Inc. Announces Proposed Public Offering of Common Stock and Warrants and Concurrent Registered Direct Offering of Common Stock
03/04/2019
HAIFA, Israel, April 03, 2019 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq: PSTI, TASE: PLTR) (“Pluristem” or “Company”), a leading regenerative medicine company developing novel placenta-based cell therapy [...]
Allogene Therapeutics Announces April 2019 Investor Conference Schedule
03/04/2019
SOUTH SAN FRANCISCO, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies [...]
MacroGenics Reports Presentation of Data at the AACR Annual Meeting 2019
03/04/2019
ROCKVILLE, MD, April 03, 2019 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
Flexion Therapeutics to Present at the 18th Annual Needham & Company Healthcare Conference
03/04/2019
BURLINGTON, Mass., April 03, 2019 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led [...]
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635 (c)(4)
03/04/2019
CAMBRIDGE, Mass., April 03, 2019 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, [...]
Rubius Therapeutics to Participate in Jefferies 6th Annual IO Cell Therapy Summit
03/04/2019
CAMBRIDGE, Mass., April 03, 2019 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is generating red blood cells and bioengineering them into an entirely new [...]
InspireMD, Inc. Announces Proposed Public Offering of Common Stock
03/04/2019
TEL AVIV, Israel, April 03, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery [...]
Recro Pharma Restructures Acute Care Segment While Continuing To Execute on Strong CDMO Segment Performance
03/04/2019
Implements Plan to Reduce Acute Care Segment Staff CDMO Segment Continues Strong Performance; Company Increases Revenue, Operating Income and EBITDA, as Adjusted* Guidance for 2019 Expects to Become Cash Flow Breakeven [...]
DBV Technologies Announces the Launch of a Proposed Global Offering of Ordinary Shares, Which May Be in the Form of American Depositary Shares
03/04/2019
Montrouge, France, April 3, 2019 DBV Technologies Announces the Launch of a Proposed Global Offering of Ordinary Shares, Which May Be in the Form of American Depositary Shares DBV Technologies (the “Company”) (Euronext [...]
DBV Technologies annonce le lancement d’une offre globale d’actions ordinaires, pouvant prendre la forme d’American Depositary Shares
03/04/2019
Montrouge, France, le 3 avril (22h00 CEST) 2019 DBV Technologies annonce le lancement d’une offre globale d’actions ordinaires, pouvant prendre la forme d’American Depositary Shares DBV Technologies (la « Société ») ( [...]
Cidara Therapeutics to Present at the 18th Annual Needham Healthcare Conference
03/04/2019
SAN DIEGO, April 03, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that Jeffrey Stein, Ph.D., [...]
Genocea to Present at 18th Annual Needham Healthcare Conference
03/04/2019
CAMBRIDGE, Mass., April 03, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today announced that Chip Clark, president and [...]
Ascendis Pharma A/S Reports Full Year 2018 Financial Results
03/04/2019
– Rare disease endocrinology pipeline continues to advance, with significant 2019 milestones anticipated – – Phase 3 heiGHt Trial results showcase potential of TransCon ™ technologies and support company algorithm for [...]
Digirad Corporation Creates Real Estate Division
03/04/2019
Purchases Three Manufacturing Plants and Enters into Lease Agreements Closes new Bank Facility SUWANEE, Ga., April 03, 2019 (GLOBE NEWSWIRE) -- Digirad Corporation (NASDAQ: DRAD) (“Digirad” or “the Company”) previously [...]
Merus Announces Financial Results for the Full Year 2018 and Provides Business Update
03/04/2019
Multiple Updates from Biclonics® Clinical Trials Expected in 2019 UTRECHT, The Netherlands, April 03, 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, “we”, “our” or the “Company”), a clinical-stage immuno- [...]
Gritstone Oncology to Present at Needham Healthcare Conference
03/04/2019
EMERYVILLE, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, [...]
Decisions Of The Extraordinary General Meeting Of Shareholders On April 01st, 2019
03/04/2019
Joint Stock Company Olainfarm has received the list of the decisions, made by the Extraordinary General meeting of shareholders on April 01st, 2019, signed by the person authorized by shareholders: 1. item of the agenda [...]
NSS Labs to Develop the 2019 Threat Detection and Analytics Systems Group Test
03/04/2019
TDA Represents an Evolution of the Original Breach Detection Systems Group Test AUSTIN, Texas, April 03, 2019 (GLOBE NEWSWIRE) -- NSS Labs, Inc., a global leader and trusted source for independent, fact-based [...]

Pages